Louis John Ptacek
Physician in San Francisco, CA
License number
Utah 177314-8905
Issued Date
Aug 4, 1987
Expiration Date
Jan 31, 2004
Category
Physician
Type
Physician/Surgeon CS (Schedule 2-5)
Address
Address
San Francisco, CA
Professional information
Investigator/Professor At Hhmi/Ucsf
Position:
Investigator/Professor at HHMI/UCSF
Location:
San Francisco Bay Area
Industry:
Research
Work:
HHMI/UCSF
-
Investigator/Professor
Education:
University of Wisconsin-Madison 1980 - 1986
Dr. Louis J Ptacek, San Francisco CA - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
1550 4Th St STE 548F, San Francisco 94158
Certifications:
Neurology, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1550 4Th St STE 548F, San Francisco 94158
Education:
Medical School
University of Wisconsin / Madison
University of Wisconsin / Madison
Louis Ptacek, San Francisco CA
Work:
Ucsf Neurology Mc 2922
1550 4Th St, San Francisco, CA 94158
1550 4Th St, San Francisco, CA 94158
Methods For Assessing Risk For Cardiac Dysrythmia In A Human Subject
US Patent:
2008022, Sep 11, 2008
Filed:
Oct 30, 2007
Appl. No.:
11/981388
Inventors:
Louis Ptacek - San Francisco CA, US
Ying-Hui Fu - San Francisco CA, US
Ying-Hui Fu - San Francisco CA, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention relates to methods for assessing the risk of a patient for developing a potentially fatal cardiac dysrhythmia and for diagnosing Andersen's Syndrome. A tissue sample from a patient is obtained and the DNA or proteins of the sample isolated. From the DNA and protein isolates the sequence of the KCNJ2 gene or the Kir2.1 polypeptide can be obtained. The KCNJ2 gene or the Kir2.1 can be screened for alteration as compared to the wile-type sequence. An alteration in a copy of the KCNJ2 gene or a Kir2.1 polypeptide indicates that the patient has a high risk for developing a cardiac dysrhythmia and can be diagnosed with Andersen's Syndrome. The invention also related to isolated nucleic acid molecules with one or more alterations as compared to the wild-type sequence.
Casein Kinase I Epsilon And Casein Kinase I Delta And Sleep In Humans
US Patent:
2006013, Jun 22, 2006
Filed:
Nov 26, 2003
Appl. No.:
10/536735
Inventors:
Louis Ptacek - San Francisco CA, US
Christopher Jones - Salt Lake City UT, US
Ying Fu - San Francisco CA, US
Christopher Jones - Salt Lake City UT, US
Ying Fu - San Francisco CA, US
International Classification:
C12Q 1/68, C07H 21/04, C12P 21/06, C12N 9/12
US Classification:
435006000, 435069100, 435194000, 435320100, 435325000, 536023200
Abstract:
Genetic variants of the casein kinase I delta and casein kinase I epsilon genes are disclosed. Herein, two novel mutant casein kinase I delta genes and a novel mutant casein kinase I epsilon gene are disclosed. The protein products of the mutant casein kinase I delta gene and the mutant casein kinase I epsilon gene are also disclosed. The nucleic acid sequences of the invention lead to familial advanced sleep phase syndrome.